Logo
V

Viela Bio

15 employees

Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Autoimmunity
Research and Development
Wellness
Biopharma
Inflammation
Maryland
Biologics
Health Diagnostics
Medical
Innovative

Date founded

2018

Funding rounds raised

Total raised

$282M

from 7 investors over 7 rounds

V

Viela Bio raised $75M on June 18, 2019

Investors: Temasek and Viking Global Investors

V

Viela Bio raised $282M on February 28, 2018

Investors: 6 Dimensions Capital, Sirona Capital, Temasek, Hillhouse Capital Management and Boyu Capital

FAQ